BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22087021)

  • 21. ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity.
    Datta G; Chaddha M; Handattu SP; Palgunachari MN; Nayyar G; Garber DW; Gupta H; White CR; Anantharamaiah GM
    Adv Exp Med Biol; 2010; 660():1-4. PubMed ID: 20221865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice.
    Bielicki JK; Zhang H; Cortez Y; Zheng Y; Narayanaswami V; Patel A; Johansson J; Azhar S
    J Lipid Res; 2010 Jun; 51(6):1496-503. PubMed ID: 20075422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2H2O-based high-density lipoprotein turnover method for the assessment of dynamic high-density lipoprotein function in mice.
    Kasumov T; Willard B; Li L; Li M; Conger H; Buffa JA; Previs S; McCullough A; Hazen SL; Smith JD
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1994-2003. PubMed ID: 23766259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement Factor H and Apolipoprotein E Participate in Regulation of Inflammation in THP-1 Macrophages.
    Nissilä E; Hakala P; Leskinen K; Roig A; Syed S; Van Kessel KPM; Metso J; De Haas CJC; Saavalainen P; Meri S; Chroni A; Van Strijp JAG; Öörni K; Jauhiainen M; Jokiranta TS; Haapasalo K
    Front Immunol; 2018; 9():2701. PubMed ID: 30519244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A human apolipoprotein E mimetic peptide reduces atherosclerosis in aged apolipoprotein E null mice.
    Xu Y; Liu H; Liu M; Li F; Liu L; Du F; Fan D; Yu H
    Am J Transl Res; 2016; 8(8):3482-92. PubMed ID: 27648138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the heparin binding sites in human apolipoprotein E.
    Saito H; Dhanasekaran P; Nguyen D; Baldwin F; Weisgraber KH; Wehrli S; Phillips MC; Lund-Katz S
    J Biol Chem; 2003 Apr; 278(17):14782-7. PubMed ID: 12588864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discrete carboxyl-terminal segments of apolipoprotein E mediate lipoprotein association and protein oligomerization.
    Westerlund JA; Weisgraber KH
    J Biol Chem; 1993 Jul; 268(21):15745-50. PubMed ID: 8340399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of apoE in inhibitory effects of apoE-rich HDL on platelet function.
    Higashihara M; Kinoshita M; Teramoto T; Kume S; Kurokawa K
    FEBS Lett; 1991 Apr; 282(1):82-6. PubMed ID: 2026270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pyrene based fluorescence approach to study conformation of apolipoprotein E3 in macrophage-generated nascent high density lipoprotein.
    Kim SH; Kothari S; Patel AB; Bielicki JK; Narayanaswami V
    Biochem Biophys Res Commun; 2014 Jul; 450(1):124-8. PubMed ID: 24866239
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The positional specificity of EXXK motifs within an amphipathic α-helix dictates preferential lysine modification by acrolein: implications for the design of high-density lipoprotein mimetic peptides.
    Zheng Y; Kim SH; Patel AB; Narayanaswami V; Iavarone AT; Hura GL; Bielicki JK
    Biochemistry; 2012 Aug; 51(32):6400-12. PubMed ID: 22800301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An apolipoprotein E mimetic peptide with activities against multidrug-resistant bacteria and immunomodulatory effects.
    Wang CQ; Yang CS; Yang Y; Pan F; He LY; Wang AM
    J Pept Sci; 2013 Dec; 19(12):745-50. PubMed ID: 24243597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.
    Tran TN; Kosaraju MG; Tamamizu-Kato S; Akintunde O; Zheng Y; Bielicki JK; Pinkerton K; Uchida K; Lee YY; Narayanaswami V
    Biochemistry; 2014 Jan; 53(2):361-75. PubMed ID: 24325674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E LDL receptor-binding domain-containing high-density lipoprotein: a nanovehicle to transport curcumin, an antioxidant and anti-amyloid bioflavonoid.
    Khumsupan P; Ramirez R; Khumsupan D; Narayanaswami V
    Biochim Biophys Acta; 2011 Jan; 1808(1):352-9. PubMed ID: 20851099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Site-specific mutagenesis of human apolipoprotein E. Receptor binding activity of variants with single amino acid substitutions.
    Lalazar A; Weisgraber KH; Rall SC; Giladi H; Innerarity TL; Levanon AZ; Boyles JK; Amit B; Gorecki M; Mahley RW
    J Biol Chem; 1988 Mar; 263(8):3542-5. PubMed ID: 2831187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein E;-low density lipoprotein receptor interaction. Influences of basic residue and amphipathic alpha-helix organization in the ligand.
    Zaiou M; Arnold KS; Newhouse YM; Innerarity TL; Weisgraber KH; Segall ML; Phillips MC; Lund-Katz S
    J Lipid Res; 2000 Jul; 41(7):1087-95. PubMed ID: 10884290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future of apolipoprotein E mimetic peptides in the prevention of cardiovascular disease.
    Valanti EK; Chroni A; Sanoudou D
    Curr Opin Lipidol; 2019 Aug; 30(4):326-341. PubMed ID: 31157629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement Factor H Binds to Human Serum Apolipoprotein E and Mediates Complement Regulation on High Density Lipoprotein Particles.
    Haapasalo K; van Kessel K; Nissilä E; Metso J; Johansson T; Miettinen S; Varjosalo M; Kirveskari J; Kuusela P; Chroni A; Jauhiainen M; van Strijp J; Jokiranta TS
    J Biol Chem; 2015 Nov; 290(48):28977-87. PubMed ID: 26468283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.
    Sharifov OF; Nayyar G; Ternovoy VV; Palgunachari MN; Garber DW; Anantharamaiah G; Gupta H
    Innate Immun; 2014 Nov; 20(8):867-80. PubMed ID: 24323453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Frank JS; Grijalva VR; Ganesh VK; Mishra VK; Palgunachari MN; Fogelman AM
    Circ Res; 2005 Sep; 97(6):524-32. PubMed ID: 16100046
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2).
    Datta G; White CR; Dashti N; Chaddha M; Palgunachari MN; Gupta H; Handattu SP; Garber DW; Anantharamaiah GM
    Atherosclerosis; 2010 Jan; 208(1):134-41. PubMed ID: 19656510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.